Circulating Tumor DNA Analysis in Pediatric cancer
Potential use of circulating tumor DNA as a biomarker in children’s cancer Pediatric cancer is the second most common cause of death in children in the developed countries, even though a highly improvement in diagnostic tools and treatment strategies occurred in the last decade. Cancer patients have to endure long treatments with many side effects, with possible multiple surgeries, and radiation.
